Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01769885
Show Display Options
Rank Status Study
1 Withdrawn Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
Conditions: Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Drug: tivozanib;   Procedure: therapeutic conventional surgery

Study has passed its completion date and status has not been verified in more than two years.